Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Fuji

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
British Journal of Haematology|October 19, 2024
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphomaMakoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, et al.
Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trialKeiji Okinaka, Yukihiro Akeda, Yoshihiro Inamoto, et al.
Annals of Hematology|May 21, 2025
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis typeHisayuki Yokoyama, Shigeo Fuji, Makoto Murata, et al.
Leukemia & Lymphoma|May 6, 2020
Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphomaKenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, et al.
Journal of Clinical Medicine|August 9, 2019
Approach to the Adult Acute Lymphoblastic Leukemia PatientValentina Sas, Vlad Moisoiu, Patric Teodorescu, et al.
Bone Marrow Transplantation|May 25, 2024
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir eraToshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, et al.
International Journal of Hematology|May 17, 2021
Expression of activated integrin β7 in multiple myeloma patientsNaoki Hosen, Satoshi Yoshihara, Hiroyuki Takamatsu, et al.
Leukemia|January 7, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partnersKazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|June 16, 2026
Improvements over time in survival after post-transplant relapse of adult T-cell leukaemia/lymphoma and trends of salvage therapy in a real-world experienceHidehiro Itonaga, Takuya Fukushima, Koji Kato, et al.
British Journal of Haematology|October 19, 2024
Comparative outcomes of various transplantation platforms, highlighting haploidentical transplants with post-transplantation cyclophosphamide for adult T-cell leukaemia/lymphomaMakoto Yoshimitsu, Takashi Tanaka, Nobuaki Nakano, et al.
Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 12, 2022
Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trialKeiji Okinaka, Yukihiro Akeda, Yoshihiro Inamoto, et al.
Annals of Hematology|May 21, 2025
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis typeHisayuki Yokoyama, Shigeo Fuji, Makoto Murata, et al.
Leukemia & Lymphoma|May 6, 2020
Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphomaKenji Nozaki, Hiroyuki Sugahara, Shuji Ueda, et al.
Journal of Clinical Medicine|August 9, 2019
Approach to the Adult Acute Lymphoblastic Leukemia PatientValentina Sas, Vlad Moisoiu, Patric Teodorescu, et al.
Bone Marrow Transplantation|May 25, 2024
Association between human herpesvirus-6 encephalitis and antiviral prophylaxis after allogeneic hematopoietic stem cell transplantation in the letermovir eraToshiki Terao, Ken-Ichi Matsuoka, Shigeo Fuji, et al.
International Journal of Hematology|May 17, 2021
Expression of activated integrin β7 in multiple myeloma patientsNaoki Hosen, Satoshi Yoshihara, Hiroyuki Takamatsu, et al.
Leukemia|January 7, 2026
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partnersKazuhisa Chonabayashi, Makoto Iwasaki, Junya Kanda, et al.
Pageof 20